Menopause and determinants of quality of life in women at midlife and beyond: The Study of Health in Pomerania (SHIP)

Menopause

Volumn 14, Issue 1, 2007, Pages 123-134

  Schwarz, Sabine ^a   Völzke, Henry ^b   Alte, Dietrich ^b   Schwahn, Christian ^b   Grabe, Hans J ^b   Hoffmann, Wolfgang ^b   John, Ulrich ^b   Dören, Martina ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Menopausal hormone therapy; Menopause; Quality of life

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOPULMONARY INSUFFICIENCY; CHRONIC DISEASE; FEMALE; GROUPS BY AGE; HORMONAL THERAPY; HUMAN; INTERVIEW; LIFESTYLE; MAJOR CLINICAL STUDY; MENOPAUSE; MENTAL DISEASE; NUTRITION; PHYSICAL DISEASE; POPULATION RESEARCH; QUALITY OF LIFE; QUESTIONNAIRE; SENSORY DYSFUNCTION; SEXUAL ABUSE; SOCIAL PSYCHOLOGY; SOCIAL STATUS; SOCIAL SUPPORT;

AFFECT; AGED; BODY MASS INDEX; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; GERMANY; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAIN; POSTMENOPAUSE; PREMENOPAUSE; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL CLASS;

EID: 33846094989     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000227860.58097.e9     Document Type: Article

References (56)

1. Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M. Measuring the impact of menopausal symptoms on quality of life. BMJ 1993;307:836-840.
2. Zethraeus N, Johannesson M, Henriksson P, Strand RT. The impact of hormone replacement therapy on quality of life and willingness to pay. Br J Obstet Gynaecol 1997;104:1191-1195.
3. Greendale GA, Reboussin BA, Hogan P, et al. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol 1998;92:982-988.
4. Barnabei VM, Grady D, Stovall DW, et al. Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol 2002;100:1209-1218.
5. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA 2002;287:591-597.
6. National Heart, Lung, and Blood Institute, National Institutes of Health. International position paper on women's health and menopause: a comprehensive approach. Office of Research on Women's Health, National Institutes of Health and Giovanni Lorenzini Medical Science Foundation. Available at: http://www.nhlbi.nih.gov/health/prof/heart/other/wm_menop.pdf. Accessed April 20, 2006.
7. Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-1854.
8. WHO Scientific Group on Research on the Menopause in the 1990s. Research on the menopause. Report of a WHO scientific group, Geneva, Switzerland. WHO Technical Report Series 866. Geneva, Switzerland: World Health Organization, 1996.
9. Nelson HD, Haney E, Humphrey L, et al. Management of menopause-related symptoms. Summary, Evidence Report/Technology Assessment No. 120. AHRQ Publication No. 05-E016-1. Rockville, MD: Agency for Healthcare Research and Quality, 2005:11-34. Available at: http://www.ahrq.gov/downloads/pub/evidence/ pdf/menopause/menopaus.pdf. Accessed September 13, 2006.
10. van Hall E, Verdel M, van der Velden J. Perimenopausal complaints in women and men: a comparative study. J Womens Health 1998;3:45-49.
11. Spetz AC, Fredriksson MG, Hammar ML. Hot flushes in a male population aged 55, 65, and 75 years, living in the community of Linkoping, Sweden. Menopause 2003;10:81-87.
12. Melby MK, Lock M, Kaufert P. Culture and symptom reporting at menopause. Hum Reprod Update 2005;11:495-512.
13. Avis NE, Assmann SF, Kravitz HM, Ganz PA, Ory M. Quality of life in diverse groups of midlife women: assessing the influence of menopause, health status and psychosocial and demographic factors. Qual Life Res 2004;13:933-946.
14. Gold EB, Block G, Crawford S, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. Am J Epidemiol 2004;159:1189-1199.
15. Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric 2004;7:375-389.
16. John U, Greiner B, Hensel E, et al. Study of Health in Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed 2001;46:186-194.
17. Schwarz S, Völzke H, Alte D, Hoffmann W, John U, Dören M. Gynaecological health care utilization and use of sex hormones - the Study of Health in Pomerania. Hum Reprod 2005;20:2916-2922.
18. von Zerssen D, Koeller D. Die Beschwerden-Liste [The Complaints Schedule]. Weinheim, Germany: Beltz, 1976.
19. Winkler J. Die Messung des sozialen Status mit Hilfe eines Index in den Gesundheitssurvey der DHP [The measurement of social status with an index for health: survey of the German cardiovascular prevention study]. RKI-Schriften 1998;1:69-74.
20. Sherbourne CD, Stewart AL. The MOS Social Support Survey. Soc Sci Med 1991;32:705-714.
21. Winkler G, Döring A. Kurzmethoden zur Charakterisierung des Ernährungsmusters: Einsatz und Auswertung eines Food-Frequency-Fragebogens [Methods for characterization of dietary pattern (short version)]. Ernährungs-Umschau 1995;42:289-291.
22. Winkler G, Döring A. Validation of a short qualitative food frequency list used in several German large scale surveys. Z Ernährungswiss 1998;37:234-241.
23. Statistisches Landesamt Mecklenburg-Vorpommern [Statistical Bureau of the State of Mecklenburg-Vorpommern]. Statistics [in Schwerin, German]. 1999.
24. Floyd F, Widaman K. Factor analysis in the development and refinement of clinical assessment instruments. Psychol Assess 1995;7:286-299.
25. Tabachnick BG, Fidell LS. Prinicipal components and factor analysis. In: Tabachnick BG, Fidell LS eds. Using Multivariate Statistics. Boston, Mass: Allyn & Bacon, 2001:582-652.
26. Greenland S, Rothman KJ. Introduction to stratified analysis. In: Rothmann KJ, Greenland S, eds. Modern Epidemiology. Philadelphia, Pa: Lippincott Williams & Wilkins, 1998:253-279.
27. Mouton C, Rodabough R, Rovi S, et al. Prevalence and 3-year incidence of abuse among postmenopausal women. Am J Public Health 2004;94:605-612.
28. Stein MB, Barrett-Connor E. Sexual assault and physical health: findings from a population-based study of older adults. Psychosom Med 2000;62:838-843.
29. Krug E, Dahlberg L, Mercy J, Zwi A, Lozano R. World Report on Violence and Health. Geneva, Switzerland: World Health Organization, 2002.
30. de Groot LC, Verheijden MW, de Henauw S, Schroll M, van Staveren WA. Lifestyle, nutritional status, health, and mortality in elderly people across Europe: a review of the longitudinal results of the SENECA study. J Gerontol A Biol Sci Med Sci 2004;59:1277-1284.
31. Hunt SM. The subjective health of older women: measuring outcomes in relation to prevention. Qual Life Res 2000;9:709-719.
32. Ekström H, Hovelius B. Quality of life and hormone therapy in women before and after menopause. Scand J Prim Health Care 2000;18:115-121.
33. Køster A, Eplov LF, Garde K. Anticipations and experiences of menopause in a Danish female general population cohort born in 1936. Arch Women Ment Health 2002;5:9-13.
34. Westerhof GJ, Barrett AE. Age identity and subjective well-being: a comparison of the United States and Germany. J Gerontol B Psychol Sci Soc Sci 2005;60:129-136.
35. Li C, Samsioe G, Borgfeldt C, Lidfeldt J, Agardh CD, Nerbrand C. Menopause-related symptoms: what are the background factors? A prospective population-based cohort study of Swedish women (the Women's Health in Lund Area Study). Am J Obstet Gynecol 2003;189:1646-1653.
36. Avis NE, McKinlay SM. A longitudinal analysis of women's attitudes toward the menopause: results from the Massachusetts Women's Health Study. Maturitas 1991;13:65-79.
37. Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 1993;168:824-830.
38. Palinkas LA, Barrett-Connor E. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 1992;80:30-36.
39. Greene JG. A factor analytic study of climacteric symptoms. J Psychosom Res 1976;20:425-430.
40. Holte A, Mikkelsen A. Psychosocial determinants of climacteric complaints. Maturitas 1991;13:205-215.
41. Dennerstein L, Smith AM, Morse C, et al. Menopausal symptoms in Australian women. Med J Aust 1993;159:232-236.
42. Calvaresi E, Bryan J. Symptom experience in Australian men and women in midlife. Maturitas 2003;44:225-236.
43. Melby MK. Factor analysis of climacteric symptoms in Japan. Maturitas 2005;52:205-222.
44. Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001;52:345-356.
45. Rothmann KJ. Measuring disease occurrence and causal effects. In: Rothmann KJ, ed. Epidemiology: An Introduction. New York, NY: Oxford University Press, 2002:24-56.
46. Kaufert P, Syrotuik J. Symptom reporting at the menopause. Soc Sci Med 1981;15:173-184.
47. Sherman S. Defining the menopausal transition. Am J Med 2005;118:3S-7S.
48. Kroke A, Schulz M, Hoffmann K, et al. Assignment to menopausal status and estimation of age at menopause for women with missing or invalid date - a probabilistic approach with weighting factors in a large-scale epidemiological study. Maturitas 2001;40:39-46.
49. den Tonkelaar I. Validity and reproducibility of self-reported age at menopause in women participating in the DOM-project. Maturitas 1997;27:117-123.
50. Colditz GA, Stampfer MJ, Willett WC. Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol 1987;126:319-325.
51. Greendale GA, Lee NP, Arriola ER. The menopause. Lancet 1999;353:571-580.
52. Bastian LA, Smith CM, Nanda K. Is this women perimenopausal? JAMA 2003;289:895-902.
53. Matthews KA, Bromberger JT. Does the menopausal transition affect health-related quality of life? Am J Med 2005;118:25S-36S.
54. World Health Organization, Regional Office for Europe, Copenhagen. Strategic Action Plan for the Health of Women in Europe. Geneva, Switzerland: World Health Organanization, 2001.
55. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
56. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712.